Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rutten

Showing results (51-60 of 356) with videos related to

Pageof 36
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Measurement and valuation of quality of life in economic appraisal of cancer treatmentC A Uyl-de Groot, F F Rutten, G J Bonsel
Pharmacoeconomics|June 6, 1996
Colony-stimulating factors and peripheral blood progenitor cell transplantation. Benefits and costsC A Uyl-de Groot, P C Huijgens, F F Rutten
Pharmacoeconomics|March 31, 2001
Healthcare resource utilisation and costs of treating NSAID-associated gastrointestinal toxicity. A multinational perspectiveC Chevat, B M Peña, M J Al, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|October 24, 2002
Antioxidants and Alzheimer's disease: from bench to bedside (and back again)Bart P F Rutten, Harry W M Steinbusch, Hubert Korr, et al.
Health Policy (Amsterdam, Netherlands)|August 2, 2002
The distribution of health planning and management responsibilities between centre and periphery: historical patterns and reform trends in four Caribbean territoriesA Mills, R Antonius, J Daniel, et al.
Journal of Medical Genetics|October 10, 1997
Cost effectiveness of DNA diagnosis for four monogenic diseasesA A van der Riet, B A van Hout, F F Rutten
Mechanisms of Ageing and Development|August 24, 2010
Caloric restriction and aging but not overexpression of SOD1 affect hippocampal volumes in miceBart P F Rutten, Ivona Brasnjevic, Harry W M Steinbusch, et al.
The American Journal of Cardiology|March 20, 1990
Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in The NetherlandsL L Martens, F F Rutten, D W Erkelens, et al.
Pharmacoeconomics|April 8, 1993
Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic modelB A van Hout, G Wielink, G J Bonsel, et al.
Mechanisms of Ageing and Development|March 29, 2003
The aging brain: less neurons could be betterBart P F Rutten, Hubert Korr, Harry W M Steinbusch, et al.
Pageof 36

Showing results (51-60 of 356) with videos related to

Sort By:
Pageof 36
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Measurement and valuation of quality of life in economic appraisal of cancer treatmentC A Uyl-de Groot, F F Rutten, G J Bonsel
Pharmacoeconomics|June 6, 1996
Colony-stimulating factors and peripheral blood progenitor cell transplantation. Benefits and costsC A Uyl-de Groot, P C Huijgens, F F Rutten
Pharmacoeconomics|March 31, 2001
Healthcare resource utilisation and costs of treating NSAID-associated gastrointestinal toxicity. A multinational perspectiveC Chevat, B M Peña, M J Al, et al.
Current Opinion in Clinical Nutrition and Metabolic Care|October 24, 2002
Antioxidants and Alzheimer's disease: from bench to bedside (and back again)Bart P F Rutten, Harry W M Steinbusch, Hubert Korr, et al.
Health Policy (Amsterdam, Netherlands)|August 2, 2002
The distribution of health planning and management responsibilities between centre and periphery: historical patterns and reform trends in four Caribbean territoriesA Mills, R Antonius, J Daniel, et al.
Journal of Medical Genetics|October 10, 1997
Cost effectiveness of DNA diagnosis for four monogenic diseasesA A van der Riet, B A van Hout, F F Rutten
Mechanisms of Ageing and Development|August 24, 2010
Caloric restriction and aging but not overexpression of SOD1 affect hippocampal volumes in miceBart P F Rutten, Ivona Brasnjevic, Harry W M Steinbusch, et al.
The American Journal of Cardiology|March 20, 1990
Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in The NetherlandsL L Martens, F F Rutten, D W Erkelens, et al.
Pharmacoeconomics|April 8, 1993
Effects of ACE inhibitors on heart failure in The Netherlands: a pharmacoeconomic modelB A van Hout, G Wielink, G J Bonsel, et al.
Mechanisms of Ageing and Development|March 29, 2003
The aging brain: less neurons could be betterBart P F Rutten, Hubert Korr, Harry W M Steinbusch, et al.
Pageof 36